The latest news from academia, regulators
research labs and other things of interest
Posted: June 3, 2008
NanoHorizons Completes a Second Successful Round of Funding
(Nanowerk News) NanoHorizons Inc. today announced that it has raised approximately $6.7 million in a second round of funding from Penn Venture Partners, L.P., Life Sciences Greenhouse of Central Pennsylvania, and a number of private investors. One-half of the investments have been funded, with the remainder to be funded (subject to attaining certain milestones) within one year. NanoHorizons, a private corporation, invents, designs, and manufactures advanced nanoparticles that add permanent, cost-effective, and environmentally friendly antimicrobial and performance-enhancing characteristics to consumer, commercial, and industrial products. The company markets its antimicrobial solution under the SmartSilver™ brand. The funding will be used to solidify and expand NanoHorizons’ business in the medical and textile markets where the demand for proven, certified antimicrobial solutions is rapidly increasing.
NanoHorizons also announced the appointment of David A. Woodle as Chairman and CEO of the company. Prior to joining NanoHorizons, Mr. Woodle was Chairman and CEO of NASDAQ-listed C-COR Incorporated, a top-tier global provider of communications equipment and management systems to the cable industry. Mr. Woodle also spent 21 years at executive and technical management positions within Raytheon Corporation, addressing Department of Defense markets for real-time information systems.
In addition, Dr. Daniel Hayes, one of the founders of NanoHorizons and an inventor of its technology, has been appointed President, COO, and member of the Board of Directors of the company. Dr. Hayes brings an extensive experience in molecular biology, developmental neuroscience, and the development and characterization of nanomaterials. He has authored numerous journal articles and holds several U.S. patents.
“With this latest round of funding, NanoHorizons is in a solid position to grow and become a leading antimicrobial brand provider,” states David Woodle. “The company brings key strengths to the marketplace. We have a proven, patent-protected product that is EPA-registered. We back our product with an experienced team of scientists, nanotechnologists, and managers. We have our own in-house research and development laboratory and manufacturing facility to foster on-going innovations. And we have allied ourselves with key strategic partners in the medical and textile markets where there is upward demand for high-performance antimicrobial solutions. Our goal is to successfully leverage these strengths with an effective and focused go-to-market strategy.”
“We are enthusiastic about the leadership and experience that Dave Woodle brings to NanoHorizons,” adds Daniel Hayes. “His success in developing businesses through astute strategic planning, strong customer relationships, and effective internal and external communications will accelerate our growth and help us make NanoHorizons’ SmartSilver the market’s antimicrobial brand of choice.”
About NanoHorizons Inc.
NanoHorizons Inc. (www.nanohorizons.com) is a leader in the emerging, cutting-edge field of practical nanotechnology for a broad range of consumer, commercial, and industrial applications. The company’s nanoscale silver antimicrobial additives, marketed globally to customers in the medical, textile, and apparel industries under the SmartSilver™ brand, uniquely offer permanent, cost-effective bacterial control in a variety of products, including natural and synthetic fibers and fabrics. A private corporation with an experienced team of scientists, technologists, and managers, NanoHorizons provides product research, design, and development, laboratory testing, manufacture, and customer support at its facilities in State College, Pennsylvania.